https://www.globallymealliance.org/blog/ravel-health?

Ravel Health is revolutionizing Lyme disease care with affordable, virtual, and personalized treatment options for chronic illness patients.

Perhaps you’ve been diagnosed with Lyme or other tick-borne illness. Maybe you’ve been suffering with chronic symptoms for years but have yet to receive a diagnosis. In either case, you want to see a Lyme literate medical provider (often referred to as LLMD), but you find yourself up against several barriers: wait-lists are months to years long. Providers don’t take insurance, and their rates are prohibitively expensive. You can’t find a provider in your area, and don’t have the energy or the means to travel. Sound familiar?

Chronic Lyme patients Kevin Williams and Jaime Intile know first-hand the frustrations that patients face in gaining access to treatment, so they’ve created a better way. Global Lyme Alliance is proud to partner with Williams and Intile’s company, Ravel Health, which specializes in matching patients with affordable, virtual care for Lyme, mold, and complex illness.

Available in ten states with the hope to be nationwide by 2025, Ravel Health offers subscription-based services that quickly match patients to vetted care teams who provide personalized telehealth including testing, treatment plans, prescriptions, and supplements.

“Ravel Health aims to simplify the Lyme journey from start to finish…”

“It can take a long time between onset of symptoms and diagnosis, and then getting a diagnosis is only half the battle,” Williams says. “We wanted to build something that we would have loved to have.” Unlike traditional medical practices, Ravel Health aims to simplify the Lyme journey from start to finish:

  • No medical gaslighting or saying “it’s all in your head”
  • No waitlists to see a vetted Lyme-literate provider
  • Personalized provider/patient matching
  • Conventional, Functional, and Integrative treatment options
  • Affordable 30, 60, or 90-minute monthly appointments with ability to upgrade or downgrade on a monthly basis
  • Significant discounts on labs and supplements
  • Everything done from the comfort of home

How does it work?

Ravel Health providers, including MDs, NDs, and NPs, go through a strict screening process. Each has at least six years of experience treating Lyme and chronic illness and is vetted through Williams and Intile themselves, and then through Ravel’s Chief Medical Officer.

After filling out a short questionnaire, patients are matched with up to three Lyme-literate providers in their state. Williams and Intile review initial questionnaires with the Chief Medical Officer to figure out the best possible fits based on individual patient preferences. Patients then choose from up to three providers. “We want patients to select providers based on fit, such as a provider’s specialties or treatment philosophy,” says Williams.

Patients also choose between affordable monthly subscription plans that offer different appointment lengths and intervals based on individual need. No matter the subscription, patients will always have ready access to providers, with guaranteed monthly appointments and guaranteed portal responses within three business days. “We believe deeply in continuity of care,” says Williams. “When a patient is having a flare, they need to be able to contact their provider or get an appointment booked. We want to make sure patients aren’t left hanging.”

Providers use evidence-supported labs and treatment protocols, personalizing them for each patient. Recommended test kits, lab orders, medications and supplements are sent directly to patient’s homes, with the option of mobile blood draws in certain areas. And Ravel Health’s simple model doesn’t just benefit patients. “We provide wraparound services so providers can focus on treatment,” Williams notes. Providers have a built-in community with whom they can share complex cases and ask questions.

What are patients saying?

Ravel Health ran a pilot from October to March with seven providers and thirty patients. The results were incredibly positive. Knowing that providers are vetted and curated, and knowing that they wouldn’t be medically gaslighted, put patients at ease. Patients know that Williams and Intile understand what they’re going through and have been through it themselves, so they trust they’re in good hands. “That piece is key for patients,” says Williams. He adds that having everything streamlined was refreshing for patients, as well as having options to choose from. Since Lyme and chronic illness strips patients of so much agency, Williams says, “We want to give patients as much choice as possible.”

Why Ravel?

Besides offering affordable, streamlined, and timely care from knowledgeable providers, Ravel focuses on the patient journey to health, as evidenced by the company’s name. With Lyme disease, life often unravels as patients fight for diagnosis, treatment, validation, and their health. Ravel Health helps patients ravel their health back together. “We are changing the way Lyme patients are treated,” says Williams.

To learn more about Williams and Intile, watch their episode on The Tick Chicks.

To learn more about Ravel Health, visit ravel.health

Ravel is available in CO, CT, IA, MN, MT, NE, PA, TX, WA & WI. To become a patient, go to https://ravel.health/get_started.

***

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2824050?#google_vignette

Abstract

Importance  Previous studies have identified mutations in SARS-CoV-2 strains that confer resistance to nirmatrelvir, yet how often this resistance arises and its association with posttreatment virologic rebound is not well understood.

Objective  To examine the prevalence of emergent antiviral resistance after nirmatrelvir treatment and its association with virologic rebound.

Design, Setting, and Participants  This cohort study enrolled outpatient adults with acute COVID-19 infection from May 2021 to October 2023. Participants were divided into those who received antiviral therapy and those who did not. The study was conducted at a multicenter health care system in Boston, Massachusetts.

Exposure  Treatment regimen, including none, nirmatrelvir (paxlovid), and remdesivir.

Main Outcomes and Measures  The primary outcome was emergent SARS-CoV-2 antiviral resistance, defined as the detection of antiviral resistance mutations, which were not present at baseline, were previously associated with decreased antiviral efficacy, and emerged during or after completion of a participant’s treatment. Next-generation sequencing was used to detect low frequency mutations down to 1% of the total viral population.

Results  Overall, 156 participants (114 female [73.1%]; median [IQR] age, 56 [38-69] years) were included. Compared with 63 untreated individuals, the 79 who received nirmatrelvir were older and more commonly immunosuppressed. After sequencing viral RNA from participants’ anterior nasal swabs, nirmatrelvir resistance mutations were detected in 9 individuals who received nirmatrelvir (11.4%) compared with 2 of those who did not (3.2%) (P = .09). Among the individuals treated with nirmatrelvir, those who were immunosuppressed had the highest frequency of resistance emergence (5 of 22 [22.7%]), significantly greater than untreated individuals (2 of 63 [3.1%]) (P = .01). Similar rates of nirmatrelvir resistance were found in those who had virologic rebound (3 of 23 [13.0%]) vs those who did not (6 of 56 [10.7%]) (P = .86). Most of these mutations (10 of 11 [90.9%]) were detected at low frequencies (<20% of viral population) and reverted to the wild type at subsequent time points. Emerging remdesivir resistance mutations were only detected in immunosuppressed individuals (2 of 14 [14.3%]) but were similarly low frequency and transient. Global Initiative on Sharing All Influenza Data analysis showed no evidence of increased nirmatrelvir resistance in the United States after the authorization of nirmatrelvir.

Conclusions and Relevance  In this cohort study of 156 participants, treatment-emergent nirmatrelvir resistance mutations were commonly detected, especially in individuals who were immunosuppressed. However, these mutations were generally present at low frequencies and were transient in nature, suggesting a low risk for the spread of nirmatrelvir resistance in the community with the current variants and drug usage patterns.

_______________

No such resistence has been seen using ivermectin and HCQ.

http://

Functional Pharmacist Analyzes Ivermectin 2024 Update

Dr. Dan Zatarski explains the mechanism of actions of Ivermectin. He reviews the discovery of ivermectin and helps to illustrate the use of ivermectin compared to penicillin.

https://justusrhope.substack.com/p/topical-ivermectin-and-fenbendazole?

Topical Ivermectin & Fenbendazole for Cancer & Disease

Multiple Case Reports & Before and After Photos

https://childrenshealthdefense.org/defender/30-lawmakers-sponsor-bill-end-liability-protection-vaccine-makers/

30 Lawmakers Sponsor Bill to End Liability Protection for Vaccine Makers

The End the Vaccine Carveout Act would end the broad protection from liability for injuries resulting from vaccines listed on the CDC’s Childhood Immunization Schedule.

liability definition and vaccine bottle

A bill introduced late last week in the U.S. House of Representatives would end the liability protections Congress gave vaccine makers under the 1986 Childhood Vaccine Injury Act.

Thirty Republican lawmakers signed on as co-sponsors to House Bill 9828, End the Vaccine Carveout Act. The proposed legislation would end the broad protection from liability for injuries resulting from vaccines listed on the Centers for Disease Control and Prevention’s (CDC) Childhood Immunization Schedule.

“The … vaccine makers are criminal enterprises that have paid tens of billions in criminal penalties over the past decade,” Children’s Health Defense (CHD) founder and chairman on leave Robert F. Kennedy Jr. said in a statement on the bill.

Kennedy, who has long advocated for eliminating liability protection for vaccine manufacturers, added, “By freeing them from liability for negligence, the 1986 statute removed any incentive for these companies to make safe products. If we want safe and effective vaccines we need to end the liability shield.”

CHD, React19 and The American Family Project also supported the development of the bill, the press release said.  (See link for article)

______________

https://news.rebekahbarnett.com.au/p/mrna-vaccine-cancer-risk-australian

Excessive DNA contamination in mRNA vaccines could cause cancer, Australian PM warned

Experts call to stop the shots until risks have been thoroughly investigated

The government should immediately suspend the use of Pfizer and Moderna Covid vaccines due to accumulating evidence of high levels of synthetic DNA contamination in the shots which presents a “substantial risk” of genomic integration and long-term health impacts, including cancers, say leading scientists and academics.  (See link for article)

________________

**Comment**

While this is a step in the right direction and should be supported by every representative despite political affiliation, much more needs to be done to protect the citizenry from a tyrannical government that has forced ‘vaccines’ on all despite a person’s health status or belief.

Go here for the latest outcome of forced vaccination in order to receive medical care.

While it has taken years to get to this point, I now am with Dr. Suzanne Humphries and Sasha Latypova, PhD on the fact ALL vaccines lower the immune system and make us vulnerable (prime us) to all manner of toxins – which can be within the vaccine itself, can trigger internal toxins/infections and make us susceptible to external toxins/infections.

For more:

https://www.thetimes.com/world/us-world/article/lyme-disease-symptoms-serena-williams-alexis-ohainan-dltvc9pcb

Lyme disease: the ‘yuppie virus’ with dangerous false diagnoses

Half a million Americans say they have it — but a slew of celebrity cases is prompting a post-Covid rethink
Bevan Hurley

The Times

Alexis Ohanian, the co-founder of Reddit and husband of the tennis star Serena Williams, was perplexed.

He was showing no symptoms of Lyme disease, and had not spent much time in the wilderness or northeastern US states where the ticks that carry it are most prevalent. And yet, after a “full battery of health scans”, his doctor had told him that he was infected.

Ohanian, 41, who lives in Florida with Williams and their two children, revealed the diagnosis to his 560,000 followers on Twitter/X last month, saying it had taken him by surprise. He was careful to ensure that his personal experience would not be taken as medical advice. “Please talk to a doctor,” he said.  (See link for article)

________________

**Comment**

First off the bat, let’s be clear: MSM hasn’t done any thinking revolving anything about COVID.

Second – if you understand ‘controllers,’ you know that intervention is eventually needed when enough people start questioning the narrative.  Since people are talking about the fact there is an estimated 500,000 NEW cases of Lyme/MSIDS per year, it’s time for the spin-doctors to get busy.  Too many are questioning things.  Too many are asking to be tested.  Too many are getting fed up with doctors who gas-light them instead of helping them.

Enter MSM – a monolithic entity paid by Big Pharma which will do anything to protect its vested interests, including lie or distort facts.

Once you’ve seen it often enough you become aware of the thinly veiled journalism designed to make you doubt what you see with your own eyes, hear with your own ears, and even personally experience.

The article starts out by regurgitating well known disputed Lyme dogma:

  • can cause fever, chills, headache, fatigue, and muscle and joint aches
  • between 5-10% descend into PTLDS and get arthritis, chronic pain, heart palpitations, and brain inflammation

Let’s stop here and state emphatically that Lyme/MSIDS can and does kill people.  Let’s also state emphatically that this complex illness can destroy your life, income, family, and all you hold dear.

OK, now that we got that out of the way…..the article then states that ‘celebrity tell-alls and rampant pseudoscience’ is fueling misdiagnoses.

What about the thousands upon thousands that have been misdiagnosed for decades with virtually everything under the sun when they were infected with Lyme/MSIDS and immediate treatment could have made a real or THE difference?

The usual perps are presented for this angle: mainly representation from the American Lyme Disease Foundation (ALDF), who are known Lyme denialists.  This representative states practitioners are ‘unqualified’ because they have no infectious disease experience and are ‘cashing in’ by selling unreliable blood testing products and treatment.

This refrain is as old as time and is shear propaganda by controllers who want you to believe that only the government can protect consumers by monopolizing testing and treatment.  Well, they have done just that for over 40 years.  Let me ask you, ‘how’s that going?’  Nowhere, that’s where.

Particularly attacked were vitamin supplements and ozone therapy – two of the safest, most effective general treatments that help virtually everything!  But since the FDA can’t do any under the table deals with Big Pharma and make money off them, they are verboten!   

The article also hones in on ‘false positives,’ with Lyme but doesn’t utter a peep over the vast false positives with COVID, along with counting all deaths as COVID, that were purposely used to create a the illusion of vast cases and deaths.

Current Lyme testing is so flawed that a statistical analysis by Cook and Puri found that the LD two-tiered testing resulted in 500 times more false-negative outcomes than similar two-tiered tests used in the diagnosis of AIDS.  

The article also pushes the highly politicized climate change agenda when there is great controversy on many issues within this highly controlled paradigm, and independent research has shown it has nothing to do with tick proliferation or transmission.

While the article is at least honest enough to recognize that countries with nationalized health care struggle even more because there’s ‘there’s no system for them to go outside of,’ and that at least in the U.S. you can still find a doctor who is independent and can think for himself/herself.  But, how long will this last?

According to the author, the oft repeated belief that more funding to the same institutions that have denied Lyme/MSIDS from the get-go is somehow the answer, despite all evidence to the contrary.

Article grade: D

https://childrenshealthdefense.org/defender/remdesivir-recall-glass-particles-covid-hospital-protocol/?

Glass Particles Prompt Another Recall of Remdesivir, the Controversial Drug Hospitals Used to Treat COVID Patients

An investigation by Gilead, maker of remdesivir, confirmed the presence of glass, according to the company recall notice posted on the FDA website warning the contaminated vials can cause stroke and “even lead to death.”

remdesivir bottles and word "recall"

Pharmaceutical giant Gilead recalled one batch of its COVID-19 antiviral drug Veklury, the brand name for remdesivir, after glass particles were discovered in vials of the drug, Newsweek reported.

A company investigation, prompted by a customer complaint, confirmed the presence of glass, according to the company recall notice posted on the U.S. Food and Drug Administration (FDA) website.

Gilead distributed the batch, identified as Veklury lot No. 47035CFA across the U.S. beginning on July 16. The batch isn’t set to expire until November 2025.

If a product containing glass is injected, it may result in localized swelling or, “the glass particulate can potentially travel, through the blood vessels, to various organs and block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death,” the company warned in the recall notice.

Gilead said it is informing distributors and customers via a letter sent to UPS Next Day Air. The letter advises facilities that have the recalled drug to stop using it and return the vials to the company following the instructions in the letter.

Gilead said it has not received any reports of adverse events related to this lot.

The company didn’t say where the lots were manufactured or by whom and did not respond to The Defender’s request for comment on those questions.  (See link for article)

________________

**Comment**

Similarly to the fact COVID tests and gene therapy injections should ALL be recalled and destroyed with a public apology, Remdesivir has been nothing but a major problem since it was rolled out as part of the ‘Fauci Death Protocol.’ 

For more:

Going back to 1997, Donald Rumsfeld chaired the Board of Directors at Gilead and after 2001 he held share packages valued at $5-25 Million. Gilead originally developed Tamiflu. George P Shultz, US Secretary of State also was on the board. He sold stocks at a value of more than $7 million. CA governor’s Pete Wilson’s wife also sat on the board.

“‘I don’t know of any biotech company that’s’ so politically well-connected [as Gilead],‘ Andrew McDonald, of the analyst firm Think Equity Partners, told Fortune.” (Source: “Virus Mania, How the Medical Industry Continually Invents Epidemics Making Billion Dollar Profits At Our Expense”)

  • Approximately $70 million in U.S. taxpayer funding began Gilead’s partnership with the U.S. Army, Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to develop remdesivir. Initially for treating Ebola, it failed to show benefit and was shelved. If remdesivir is used to treat COVID-19, Gilead shareholders, not the taxpayers, will profit.

Please remember:

  • There were more than 500 deaths in the first year of remdesivir usage.
  • There have been 20 deaths in 19 years of ivermectin usage.
  • The FDA, spurred by “multiple” reports of ivermectin ‘poisoning,’ lied when it put out a post on it causing “serious harm, seizures, coma, and even death”.  When the author inquired on how many is “multiple,” she was told FOUR.  Yet, the FDA had no trouble approving remdesivir which has caused far more deaths.
  • CDC also bad-mouthed ivermectin and pushed the “calls to the poison control center” narrative. The problem is they gave no data to support this claim.